34
Investment Highlights
• Uniquely positioned company within the
large and growing medical and recreational
marijuana industry
• Clear strategy across three verticals of marijuana
production, patient education,
and pharmaceutical production
• High quality experienced management
team who have aligned interests with
shareholders by investing $6MM, and a track
record of building successful multi-billion
dollar companies
• State of the art production facility in Paris,
Ontario in operation with first sales acheived
in August, 2016
• Expansion capacity allowing a total annual
production of 21,000KG